However, another fibrosis marker in the angiotensin-II/TGF-β pathway, the connective tissue growth factor (Ctgf) was up-regulated significantly compared to the sham-operated group, indicating an active fibrotic process in CKD at week 13 (Table 3). The gene discussed is TGFB1; the disease is chronic kidney disease.